Nyra health raises €20m for digital neurotherapy
Nyra health has raised €20m to scale its digital neurotherapy platform for neurological rehabilitation, targeting conditions such as stroke and dementia.
The Series A funding will be used to expand the company’s technology across the DACH region, accelerate its expansion into the US and support a more data-driven approach to neurorehabilitation.
Founded in 2021, Vienna-based nyra health has developed a certified medical device called myReha. Patients use the platform to train speech, cognition, fine motor skills and everyday abilities, supported by AI-driven real-time feedback.
The system analyses pathological speech, meaning speech affected by neurological damage, by assessing pronunciation, word retrieval, sentence structure and meaning. It also tracks reaction times, error patterns and training progress, adapting therapy automatically to a patient’s performance level and fatigue.
The company says neurological conditions including stroke, dementia and traumatic brain injury cost €65bn a year in Germany alone, largely because care often declines after patients are discharged from hospital.
Nyra health says myReha is used in more than 100 rehabilitation clinics and is reimbursed by 28 statutory and private health insurers, giving over 40m insured people access to structured, AI-based home therapy. According to the company, a randomised controlled study found that adding myReha to standard therapy led to greater improvements in language and cognitive function than standard therapy alone.
A companion tool, nyra insights, allows therapists to monitor language development, therapy intensity and progress in real time, adjust programmes and generate documentation automatically. An AI-supported Content Studio creates personalised therapy exercises based on individual performance data.
The funding round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma also participating. It follows a €4.5m seed round raised in 2023.
Moritz Schöllauf, chief executive and co-founder of nyra health, said:
“From the outset, our goal was to make our services widely available to those affected. Everyone who needs therapy after a stroke or other neurological disease should have access to effective, individualised care, regardless of where they live or how well their own healthcare system is set up. With this round of financing, we are taking another step in this direction.”
Christian Figge, managing partner at Armira Growth, said:
“Neurological rehabilitation can be made significantly more effective through digital solutions, especially in the area of speech ability. nyra health is considered a category creator with a proprietary AI-based solution that connects inpatient therapy, outpatient aftercare and home use.”
The company is also investing in multimodal AI models for therapeutic interaction and diagnostics as part of a €4.2m funded research project being developed with research universities in the US.
